Inside Drug Pricing - 11/04/2019

Pfizer Willing To Pay More In Part D For Beneficiary Out-Of-Pocket Caps

By Rachel Cohrs / October 31, 2019 at 11:32 AM
Pfizer CEO Albert Bourla on Tuesday (Oct. 29) told investors that the company would be willing to pay a larger share of costs in Medicare Part D in exchange for a cap on beneficiaries’ out-of-pocket costs. He blamed increasing beneficiary cost-sharing for souring public sentiment on drug makers. “I would tell you that we are fanatically in favor of reducing out-of-pocket cost for patients. Because right now the fundamental issue that drives this polarization in the political environment around healthcare,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.